Skip to main content
. 2016 Sep 16;7(45):73865–73875. doi: 10.18632/oncotarget.12076

Figure 2. The ROC curves of nLNR, npLNs (TDs plus pLNs), LNR, and pLNs for predicting DFS and OS in all patients.

Figure 2

A. The AUC of nLNR, npLNs, LNR, and pLNs for predicting DFS were: 0.686 (95% CI 0.663-0.710), 0.681 (95% CI 0.657-0.704), 0.668 (95% CI 0.644-0.691), and 0.664 (95% CI 0.640-0.688), respectively (all P<0.0001). B. The AUC of nLNR, LNR, npLNs, and pLNs for predicting OS were: 0.672 (95% CI 0.648-0.697), 0.667 (95% CI 0.643-0.692), 0.663 (95% CI 0.638-0.688), and 0.659 (95% CI 0.635-0.684), respectively (all P<0.0001).